C16H19N3O6
Neat
349.34
MITOMYCIN B; 4055-40-7; HSDB 3419; VT1IGL3D7V; [(4S, 6S, 7R, 8R)-7-hydroxy-11-methoxy-5, 12-dimethyl-10, 13-dioxo-2, 5-diazatetracyclo[7.4.0.02, 7.04, 6]trideca-1(9), 11-dien-8-yl]methyl carbamate; CHEBI:85416; DTXSID001318185; Azirino(2', 3':3, 4)pyrrolo(1, 2-a)indole-4, 7-dione, 1, 1a, 2, 8, 8a, 8b-hexahydro-8a-hydroxy-8-(hydroxymethyl)-6-methoxy-1, 5-dimethyl-, 8-carbamate; NSC75987; ((4S, 6S, 7R, 8R)-7-hydroxy-11-methoxy-5, 12-dimethyl-10, 13-dioxo-2, 5-diazatetracyclo(7.4.0.02, 7.04, 6)trideca-1(9) and 11-dien-8-yl)methyl carbamate; RefChem:159094; DTXCID301747973; Mitomycin EP Impurity C; UNII-VT1IGL3D7V; MITOMYCIN B [MI]; MITOMYCIN B [HSDB]; SCHEMBL783139; CHEMBL323536; UZUUQCBCWDBYCG-DQRAMIIBSA-N; MITOMYCIN IMPURITY C [EP IMPURITY]
[(4S, 6S, 7R, 8R)-7-hydroxy-11-methoxy-5, 12-dimethyl-10, 13-dioxo-2, 5-diazatetracyclo[7.4.0.02, 7.04, 6]trideca-1(9) and 11-dien-8-yl]methyl carbamate
InChI=1S/C16H19N3O6/c1-6-11(20)10-9(12(21)13(6)24-3)7(5-25-15(17)22)16(23)14-8(18(14)2)4-19(10)16/h7-8,14,23H,4-5H2,1-3H3,(H2,17,22)/t7-,8-,14-,16+,18?/m0/s1